| Cancer-related inflammation and treatment effectiveness CI Diakos, KA Charles, DC McMillan, SJ Clarke The Lancet Oncology 15 (11), e493-e503, 2014 | 1858 | 2014 |
| The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer JCY Chan, DL Chan, CI Diakos, A Engel, N Pavlakis, A Gill, SJ Clarke Annals of surgery 265 (3), 539, 2017 | 291 | 2017 |
| Dual somatostatin receptor/FDG PET/CT imaging in metastatic neuroendocrine tumours: proposal for a novel grading scheme with prognostic significance DLH Chan, N Pavlakis, GP Schembri, EJ Bernard, E Hsiao, A Hayes, ... Theranostics 7 (5), 1149, 2017 | 241 | 2017 |
| Studies of a Cobalt (III) Complex of the MMP Inhibitor Marimastat: A Potential Hypoxia‐Activated Prodrug TW Failes, C Cullinane, CI Diakos, N Yamamoto, JG Lyons, TW Hambley Chemistry-A European Journal 13 (10), 2974-2982, 2007 | 174 | 2007 |
| Radiation, inflammation and the immune response in cancer KJ McKelvey, AL Hudson, M Back, T Eade, CI Diakos Mammalian Genome 29 (11-12), 843-865, 2018 | 158 | 2018 |
| A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers JK Sabari, M Offin, D Stephens, A Ni, A Lee, N Pavlakis, S Clarke, ... JNCI: Journal of the National Cancer Institute 111 (6), 575-583, 2018 | 121 | 2018 |
| Cancer‐related systemic inflammation: the challenges and therapeutic opportunities for personalized medicine D Shinko, CI Diakos, SJ Clarke, KA Charles Clinical Pharmacology & Therapeutics 102 (4), 599-610, 2017 | 87 | 2017 |
| Prognostic and predictive biomarkers in neuroendocrine tumours DL Chan, SJ Clarke, CI Diakos, PJ Roach, DL Bailey, S Singh, N Pavlakis Critical reviews in oncology/hematology 113, 268-282, 2017 | 65 | 2017 |
| A data-driven, knowledge-based approach to biomarker discovery: application to circulating microRNA markers of colorectal cancer prognosis F Vafaee, C Diakos, MB Kirschner, G Reid, MZ Michael, LG Horvath, ... NPJ systems biology and applications 4 (1), 20, 2018 | 55 | 2018 |
| A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial remeasurement JCY Chan, CI Diakos, DLH Chan, A Engel, N Pavlakis, A Gill, SJ Clarke Annals of surgery 267 (6), 1119-1125, 2018 | 37 | 2018 |
| Investigations into the interactions between DNA and conformationally constrained pyridylamineplatinum (II) analogues of AMD473 VP Munk, CI Diakos, LT Ellis, RR Fenton, BA Messerle, TW Hambley Inorganic chemistry 42 (11), 3582-3590, 2003 | 37 | 2003 |
| Glycolysis and fatty acid oxidation inhibition improves survival in glioblastoma KJ McKelvey, EB Wilson, S Short, AA Melcher, M Biggs, CI Diakos, ... Frontiers in Oncology 11, 633210, 2021 | 32 | 2021 |
| Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre M Itchins, J Arena, CB Nahm, J Rabindran, S Kim, E Gibbs, S Bergamin, ... European Journal of Surgical Oncology 43 (9), 1711-1717, 2017 | 31 | 2017 |
| Structure, Stability, and Interconversion Barriers of the Rotamers of cis-[PtIICl2 (quinoline) 2] and cis-[PtIICl2 (3-bromoquinoline)(quinoline)] from X-ray Crystallography … MS Davies, CI Diakos, BA Messerle, TW Hambley Inorganic chemistry 40 (13), 3048-3054, 2001 | 22 | 2001 |
| Are in vitro human blood–brain–tumor-barriers suitable replacements for in vivo models of brain permeability for novel therapeutics? A Prashanth, H Donaghy, SP Stoner, AL Hudson, HR Wheeler, CI Diakos, ... Cancers 13 (5), 955, 2021 | 21 | 2021 |
| Temporal and spatial modulation of the tumor and systemic immune response in the murine Gl261 glioma model KJ McKelvey, AL Hudson, R Prasanna Kumar, JS Wilmott, GH Attrill, ... PLoS One 15 (4), e0226444, 2020 | 21 | 2020 |
| Synthesis, characterisation and in vitro cytotoxicity studies of a series of chiral platinum (II) complexes based on the 2-aminomethylpyrrolidine ligand: X-ray crystal … CI Diakos, M Zhang, PJ Beale, RR Fenton, TW Hambley European journal of medicinal chemistry 44 (7), 2807-2814, 2009 | 17 | 2009 |
| Equivocal ALK fluorescence in‐situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing C Selinger, W Cooper, T Lum, C McNeil, A Morey, P Waring, B Amanuel, ... Histopathology 67 (5), 654-663, 2015 | 16 | 2015 |
| DNA adducts of the enantiomers of the Pt (II) complexes of the ahaz ligand (ahaz= 3-aminohexahydroazepine) and recognition of these adducts by HMG domain proteins J Malina, M Vojtiskova, V Brabec, CI Diakos, TW Hambley Biochemical and biophysical research communications 332 (4), 1034-1041, 2005 | 12 | 2005 |
| Identification by NMR Spectroscopy of the Two Stereoisomers of the Platinum Complex [PtCl2 (S-ahaz)](S-ahaz= 3 (S)-Aminohexahydroazepine) Bound to a DNA 14-mer Oligonucleotide … CI Diakos, BA Messerle, P del Socorro Murdoch, JA Parkinson, PJ Sadler, ... Inorganic chemistry 48 (7), 3047-3056, 2009 | 11 | 2009 |
Stephen ClarkeProfessor of Medicine, University of Sydney and Medical Oncologist, RNSH and Genesis CareVerified email at sydney.edu.au
